English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
American Cancer Society Cancer Action Network
+
Regulatory
Press release submission
| Jul 31, 2018
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK: Massachusetts Joins Ranks of States Preventing Tobacco Sales to Youth Under 21, Becomes First State to Pass Tobacco Sale Ban
+
Regulatory
Press release submission
| Jul 25, 2018
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK: ACS CAN Letter: Drug Pricing Policy Should Prioritize Patient Affordability
+
Regulatory
Press release submission
| Jul 4, 2018
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK: State Bills Limiting Local Authority Could Threaten Future Public Health Policies
+
Regulatory
Press release submission
| Jun 28, 2018
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK: Association Health Plan Rule Likely to Divide Insurance Market; Strip Patient Protections
+
Regulatory
Press release submission
| May 29, 2018
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK: Patient Safety in Jeopardy Under Senate Right-to-Try Proposal
+
Regulatory
Press release submission
| May 22, 2018
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK: New Law Regulating ‘Step Therapy’ Puts Patients First
+
Regulatory
Press release submission
| May 8, 2018
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK: American Cancer Society Cancer Action Network Testifies Against Medicaid Work Requirement Legislation
Press release submission
| Apr 26, 2018
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK: CDC Launches New Round of Powerful Tobacco Cessation Ads
Trending
+
Pharmaceuticals
Patient Daily
| Aug 4, 2026
Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+
Pharmaceuticals
Patient Daily
| Aug 6, 2026
FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+
Regulatory
M. R. Armstrong
| Aug 4, 2026
Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+
Pharmaceuticals
Patient Daily
| Aug 5, 2026
Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes
1
2
3
»
Last »